POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2

Genes Chromosomes Cancer. 2023 Aug;62(8):460-470. doi: 10.1002/gcc.23136. Epub 2023 Mar 31.

Abstract

Gene fusions involving EWSR1 or FUS as the 5' partner have been reported in a diverse array of sarcomas. Here, we characterize the histopathology and genomics of six tumors harboring a gene fusion between EWSR1 or FUS and POU2AF3, an understudied, putative colorectal cancer predisposition gene. Striking morphologic features reminiscent of synovial sarcoma were observed including a biphasic appearance with variable fusiform to epithelioid cytomorphology and staghorn-type vasculature. RNA sequencing demonstrated variable breakpoints in EWSR1/FUS along with similar breakpoints in POU2AF3 that encompassed a 3' portion of this gene. For cases in which additional information was available, the behavior of these neoplasms was aggressive with local spread and/or distant metastases. Although further studies are needed to confirm the functional significance of our findings, POU2AF3 fusions to EWSR1 or FUS may define a novel type of POU2AF3-rearranged sarcomas with aggressive, malignant behavior.

Keywords: COLCA2; EWSR1; POU2AF3; comprehensive genomic profiling; round-cell sarcoma; synovial sarcoma.

MeSH terms

  • Biomarkers, Tumor / genetics
  • Gene Fusion
  • Humans
  • In Situ Hybridization, Fluorescence
  • Neoplasm Proteins / genetics
  • Oncogene Proteins, Fusion / genetics
  • RNA-Binding Protein EWS / genetics
  • RNA-Binding Protein FUS / genetics
  • Sarcoma* / genetics
  • Sarcoma, Synovial*
  • Soft Tissue Neoplasms* / genetics

Substances

  • RNA-Binding Protein EWS
  • Biomarkers, Tumor
  • Oncogene Proteins, Fusion
  • EWSR1 protein, human
  • COLCA2 protein, human
  • Neoplasm Proteins
  • FUS protein, human
  • RNA-Binding Protein FUS